Request Deal Involvement
ARCH Venture Partners and TCGX led a $73.9m Series C round in Arbor Biotechnologies.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
pr advisors
Verge Scientific Communications
legal advisors
Ropes & Gray
or
Principals
target
ARBOR BIOTHECHNOLOGIES
bidder
QATAR INVESTMENT AUTHORITY
bidder
ARCH VENTURE PARTNERS
bidder
TCGX
bidder
T. ROWE PRICE GROUP INC
bidder
PARTNERS INVESTMENT
bidder
REVELATION PARTNERS
bidder
KERNA VENTURES
bidder
ABRDN INC
bidder
TEMASEK HOLDINGS LIMITED
bidder
ALLY BRIDGE GROUP
bidder
ARROWMARK PARTNERS
bidder
DEEP TRACK CAPITAL
bidder
PIPER HEARTLAND HEALTHCARE CAPITAL
bidder
SURVEYOR CAPITAL
bidder
VERTEX PHARMACEUTICALS INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite